Jiangsu Apon Medical Technology Co., Ltd.
Simbol: 300753.SZ
SHZ
12.98
CNYTržna cena danes
-103.9099
Razmerje P/E
0.0000
Razmerje PEG
1.64B
Kapaciteta MRK
- 0.00%
Donos DIV
Jiangsu Apon Medical Technology Co., Ltd. (300753-SZ) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 249.3 | 274.7 | 388.6 | |||||||||
balance-sheet.row.short-term-investments | 0 | -22.7 | -7.6 | -1.5 | |||||||||
balance-sheet.row.net-receivables | 0 | 133.6 | 139.2 | 102.3 | |||||||||
balance-sheet.row.inventory | 0 | 61 | 67.4 | 31.7 | |||||||||
balance-sheet.row.other-current-assets | 0 | 1.5 | 2.9 | 0.7 | |||||||||
balance-sheet.row.total-current-assets | 0 | 445.4 | 484.2 | 523.3 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 207 | 212.8 | 168.6 | |||||||||
balance-sheet.row.goodwill | 0 | 53.2 | 69.4 | 33.9 | |||||||||
balance-sheet.row.intangible-assets | 0 | 35.6 | 33.2 | 37.7 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 88.8 | 102.6 | 71.6 | |||||||||
balance-sheet.row.long-term-investments | 0 | 103.8 | 87 | 60.5 | |||||||||
balance-sheet.row.tax-assets | 0 | 24.4 | 8.7 | 2.1 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.8 | 3.7 | 1.2 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 424.8 | 414.9 | 303.9 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 870.2 | 899.1 | 827.2 | |||||||||
balance-sheet.row.account-payables | 0 | 46.9 | 27.8 | 31.4 | |||||||||
balance-sheet.row.short-term-debt | 0 | 33.8 | 2 | -3.4 | |||||||||
balance-sheet.row.tax-payables | 0 | 6.6 | 8.5 | 14.5 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 34.5 | 39.9 | 3.7 | |||||||||
Deferred Revenue Non Current | 0 | 1.9 | 2 | 2 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 1.6 | 42.3 | 53.8 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 36.7 | 42 | 2.2 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 34.5 | 39.9 | 3.7 | |||||||||
balance-sheet.row.total-liab | 0 | 183.9 | 118.5 | 87.4 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 126 | 126 | 105 | |||||||||
balance-sheet.row.retained-earnings | 0 | 188.1 | 264.5 | 247.1 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 41.5 | 41.5 | 36.5 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 329.9 | 347.6 | 350.9 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 685.6 | 779.6 | 739.5 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 870.2 | 899.1 | 827.2 | |||||||||
balance-sheet.row.minority-interest | 0 | 0.8 | 0.9 | 0.3 | |||||||||
balance-sheet.row.total-equity | 0 | 686.4 | 780.5 | 739.8 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 81.1 | 79.4 | 59 | |||||||||
balance-sheet.row.total-debt | 0 | 68.4 | 39.9 | 3.7 | |||||||||
balance-sheet.row.net-debt | 0 | -180.9 | -234.8 | -384.8 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -76.5 | 53.3 | 96.9 | |||||||||
cash-flows.row.depreciation-and-amortization | 0 | 19.6 | 15.4 | 9.7 | |||||||||
cash-flows.row.deferred-income-tax | 0 | -15.5 | -6.6 | 0.7 | |||||||||
cash-flows.row.stock-based-compensation | 0 | 15.5 | 6.6 | -0.7 | |||||||||
cash-flows.row.change-in-working-capital | 0 | 28.3 | -76.7 | -25.8 | |||||||||
cash-flows.row.account-receivables | 0 | 9.1 | -47.6 | -34 | |||||||||
cash-flows.row.inventory | 0 | 6.3 | -33.6 | -3.3 | |||||||||
cash-flows.row.account-payables | 0 | 28.4 | 11.1 | 10.7 | |||||||||
cash-flows.row.other-working-capital | 0 | -15.5 | -6.6 | 0.7 | |||||||||
cash-flows.row.other-non-cash-items | 0 | 4.1 | 26.3 | 2.6 | |||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -24.2 | -39.6 | -35.6 | |||||||||
cash-flows.row.acquisitions-net | 0 | 0.1 | -37.3 | 2.7 | |||||||||
cash-flows.row.purchases-of-investments | 0 | -3 | -22.5 | -52.4 | |||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 259 | 0.1 | 0.8 | |||||||||
cash-flows.row.other-investing-activites | 0 | -256.7 | 2.5 | 1.5 | |||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -24.8 | -96.7 | -83.1 | |||||||||
cash-flows.row.debt-repayment | 0 | -29.4 | 0 | -0.4 | |||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.dividends-paid | 0 | -0.6 | -31.5 | -32.3 | |||||||||
cash-flows.row.other-financing-activites | 0 | 54 | -4.3 | 0.4 | |||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 23.9 | -35.8 | -32.3 | |||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.net-change-in-cash | 0 | -25.5 | -114.3 | -32 | |||||||||
cash-flows.row.cash-at-end-of-period | 0 | 248.8 | 274.3 | 388.6 | |||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 274.3 | 388.6 | 420.6 | |||||||||
cash-flows.row.operating-cash-flow | 0 | -24.6 | 18.3 | 83.3 | |||||||||
cash-flows.row.capital-expenditure | 0 | -24.2 | -39.6 | -35.6 | |||||||||
cash-flows.row.free-cash-flow | 0 | -48.8 | -21.3 | 47.7 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 323.8 | 461.2 | 443.1 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 163.8 | 166.3 | 188.6 | |||||||||
income-statement-row.row.gross-profit | 0 | 160 | 294.9 | 254.5 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.operating-expenses | 0 | 232 | 235.5 | 146.3 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 395.7 | 401.8 | 334.9 | |||||||||
income-statement-row.row.interest-income | 0 | 2.1 | 3.6 | 7.2 | |||||||||
income-statement-row.row.interest-expense | 0 | 2.5 | 1.1 | 0 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.interest-expense | 0 | 2.5 | 1.1 | 0 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 19.6 | 15.4 | 9.7 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | -88.3 | 55.8 | 113.5 | |||||||||
income-statement-row.row.income-before-tax | 0 | -90.7 | 55.3 | 111.9 | |||||||||
income-statement-row.row.income-tax-expense | 0 | -14.2 | 2 | 15 | |||||||||
income-statement-row.row.net-income | 0 | -76.4 | 54.1 | 97 |
Pogosto zastavljeno vprašanje
Kaj je Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) skupna sredstva?
Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) skupna sredstva so 870213234.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.567.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je -0.266.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je -0.043.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so -0.061.
Kaj je Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je -76377405.540.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 68373296.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 231973871.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.